Carson Wealth (CWM LLC)
NPCE icon

Carson Wealth (CWM LLC)’s Neuropace NPCE Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.7K Buy
1,343
+1,187
+761% +$17.8K ﹤0.01% 4488
2025
Q4 		$2K Sell
156
-72
-32% -$963 ﹤0.01% 5115
2025
Q3 		$2K Sell
228
-52
-19% -$490 ﹤0.01% 5026
2025
Q2 		$3K Sell
280
-40
-13% -$500 ﹤0.01% 4792
2025
Q1 		$4K Buy
320
+122
+62% +$1.53K ﹤0.01% 4558
2024
Q4 		$2K Buy
198
+19
+11% +$165 ﹤0.01% 4576
2024
Q3 		$1K Buy
179
+13
+8% +$95 ﹤0.01% 4645
2024
Q2 		$1K Hold
166
– – ﹤0.01% 4434
2024
Q1 		$2K Buy
+166
New +$2.37K ﹤0.01% 4011

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Carson Wealth (CWM LLC)'s NPCE Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Neuropace (NPCE) stake by 761% in Q1 2026, buying an estimated $17.8K and bringing the position to 1,343 shares worth $17.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4488.

Carson Wealth (CWM LLC) first reported a position in NPCE in Q1 2024 and has held it in 9 quarters since. 113 funds tracked by Wall St. Rank hold NPCE as of Q1 2026.

  • Carson Wealth (CWM LLC) held 1,343 shares of Neuropace worth $17.7K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 1,187 Neuropace shares in Q1 2026, an estimated $17.8K.
  • Neuropace made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4488 holding.
  • Carson Wealth (CWM LLC) first reported a position in Neuropace in Q1 2024 and has held it in 9 quarters since.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.